(in millions $) | 1 May 2023 | 31 Jan 2023 | 30 Oct 2022 | 1 May 2022 |
---|---|---|---|---|
Current assets | ||||
Cash | $205 | |||
Short term investments | ||||
Net receivables | $2702 | |||
Inventory | $2316 | |||
Total current assets | $8466 | |||
Long term investments | ||||
Property, plant & equipment | $6881 | |||
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $18140 | |||
Current liabilities | ||||
Accounts payable | $1998 | |||
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $3719 | |||
Long term debt | $2250 | |||
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $7148 | |||
Shareholders' equity | ||||
Retained earnings | $6043 | |||
Other shareholder equity | $187 | |||
Total shareholder equity |
(in millions $) | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 | 30 Jan 2020 |
---|---|---|---|---|
Current assets | ||||
Cash | $342 | $3006 | $2607 | |
Short term investments | ||||
Net receivables | $2174 | $1465 | $1380 | |
Inventory | $1978 | $1841 | $1691 | |
Total current assets | $7834 | $7610 | $6257 | |
Long term investments | ||||
Property, plant & equipment | $5778 | $4596 | $4007 | |
Goodwill & intangible assets | ||||
Total noncurrent assets | $6844 | $5611 | ||
Total investments | ||||
Total assets | $16413 | $14454 | $11868 | |
Current liabilities | ||||
Accounts payable | $1582 | $2132 | $1781 | |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $2965 | $3053 | $2064 | |
Long term debt | $2539 | $1826 | $1899 | |
Total noncurrent liabilities | $2895 | $2693 | ||
Total debt | ||||
Total liabilities | $6896 | $5948 | $4757 | |
Shareholders' equity | ||||
Retained earnings | $4539 | $3599 | $2747 | |
Other shareholder equity | $362 | $781 | $543 | |
Total shareholder equity |
(in millions $) | 1 May 2023 | 31 Jan 2023 | 30 Oct 2022 | 1 May 2022 |
---|---|---|---|---|
Revenue | ||||
Total revenue | ||||
Cost of revenue | ||||
Gross Profit | ||||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | ||||
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | ||||
Interest expense | ||||
Net income | ||||
Net income | ||||
Income (for common shares) |
(in millions $) | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 | 30 Jan 2020 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $12761 | $10219 | $9556 | |
Cost of revenue | ||||
Gross Profit | $5092 | $3789 | $3696 | |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $2548 | $2466 | $2493 | |
Operating income | $1323 | $1203 | ||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $307 | $159 | $156 | |
Interest expense | -$463 | |||
Net income | ||||
Net income | $1711 | $1106 | $1032 | |
Income (for common shares) |
(in millions $) | 2 Aug 2022 | 31 Jan 2022 | 3 Aug 2021 | 29 Jul 2021 |
---|---|---|---|---|
Net income | $779 | |||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | $1285 | |||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | -$2007 | -$1865 | -$847 | -$685 |
Financing activities | ||||
Dividends paid | -$103 | -$205 | -$90 | -$90 |
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | -$385 | -$1369 | $117 | $147 |
Effect of exchange rate | -$5 | -$9 | -$4 | -$4 |
Change in cash and equivalents | -$197 | $219 | $743 | $743 |
(in millions $) | 31 Jan 2022 | 30 Jan 2021 | 30 Jan 2020 | 30 Jan 2019 |
---|---|---|---|---|
Net income | $1108 | $1033 | $1293 | |
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | $2093 | $1869 | $1845 | |
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | -$1865 | -$2043 | -$1172 | -$1212 |
Financing activities | ||||
Dividends paid | -$205 | -$174 | -$216 | -$220 |
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | -$1369 | $348 | -$343 | -$122 |
Effect of exchange rate | -$9 | $1 | -$13 | -$4 |
Change in cash and equivalents | $219 | $399 | $341 | $507 |
Market cap | N/A |
---|---|
Enterprise value | N/A |
Shares outstanding | N/A |
Revenue | N/A |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | N/A |
---|---|
ROA | N/A |
ROE | N/A |
Debt/Equity | N/A |
---|---|
Net debt/EBITDA | N/A |
Current ratio | N/A |
Quick ratio | N/A |